Intensity Therapeutics, Inc. Common stock (INTS)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $10.13M
Last updated: Nov 17, 2026 at 4:10 PM ET
Intensity Therapeutics, Inc. Common stock (INTS) Stock Chart
Intensity Therapeutics, Inc. Common stock (INTS) has a latest price of $2.66 on Nov 17, 2026. Its price fell 75.7% over the past 12 months. The month-end price fell 95.5% over the 3 years through Oct 2026, a compound annual decline of 64.5%.
Price Chart
From Jun 2023 to Oct 2026, its highest month-end close was $214.25 in Dec 2023 and its lowest $3.37 in Sep 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart INTS with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for INTS.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 36.7%, and over 6 months it fell 42.0%.
| Period | Change |
|---|---|
| 1 month | -19.1% |
| 3 months | -36.7% |
| 6 months | -42.0% |
| 12 months | -75.7% |
| 12 months, with dividends | -75.7% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -95.5% | -64.5% |
Price by Year
Its best calendar year was 2025, when the price fell 76.7%, and its weakest was 2024, when it fell 79.5%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $3.40 | -66.8% |
| 2025 | $10.26 | -76.7% |
| 2024 | $44.00 | -79.5% |
Trading Range
The price is 23.6% below its 50-day average of $3.48 and 44.9% below its 200-day average of $4.83.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $2.66 | |
| 50-day average | $3.48 | -23.6% |
| 200-day average | $4.83 | -44.9% |
Price Risk
Over 3 years, its largest fall from a peak was 98.9%.
| Measure | Value |
|---|---|
| 1-year beta | 1.36 |
| Largest fall, 1 year | -82.0% |
| Largest fall, 3 years | -98.9% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About INTS
What is INTS's 1-year price change?
Intensity Therapeutics, Inc. Common stock's price fell 75.7% over the past 12 months. With dividends included, the 12-month total return was -75.7%.
How has INTS stock done over the long term?
Intensity Therapeutics, Inc. Common stock's month-end price fell 95.5% over the 3 years through Oct 2026, a compound annual decline of 64.5%. These figures leave out dividends.
What is INTS's beta?
Intensity Therapeutics, Inc. Common stock's 1-year beta against the S&P 500 is 1.36, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 82.0%.
Is the INTS chart free?
Yes. Advanced Charting for INTS is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
INTS pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors